Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q4 2025 vs. Q3 2025
How the institutions holding Sunshine Biopharma Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 14 | 13 | −1 |
| Shares | 226.4K | 115.0K | −111.4K (−49.2%) |
| Value | $337.3K | $141.7K | −$195.7K (−58.0%) |
New holders (4)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 23,388 | $29.0K | 0.00% |
| XTX Topco Ltd | 16,156 | $19.9K | 0.00% |
| SageView Advisory Group, LLC | 1 | $2 | 0.00% |
| Strive Financial Group ,LLC | 1 | $1 | 0.00% |
Sold out (5)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Renaissance Technologies LLC | 55,700 | $83.0K |
| DRW Securities, LLC | 44,977 | $67.0K |
| Two Sigma Investments, LP | 21,399 | $31.9K |
| Two Sigma Securities, LLC | 17,176 | $25.6K |
| Federation des caisses Desjardins du Quebec | 1 | $1 |